References
- Giudice LC , KaoLC. Endometriosis. Lancet364(9447) , 1789–1799 (2004).
- Munksgaard PS , BlaakaerJ. The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol. Oncol.123(1) , 157–163 (2011).
- Jimbo H , HitomiY, YoshikawaH et al. Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am. J. Pathol. 150(4) , 1173–1178 (1997).
- Prowse AH , ManekS, VarmaR et al. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int. J. Cancer 119(3) , 556–562 (2006).
- Sato N , TsunodaH, NishidaM et al. Loss of heterozygosity on and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 60(24) , 7052–7076 (2000).
- Yamamoto S , TsudaH, TakanoM, IwayaK, TamaiS, MatsubaraO. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma. J. Pathol.225(2) , 189–194 (2011).
- Wiegand KC , ShahSP, Al-AghaOM et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med.363(16) , 1532–1543 (2010).
- Kurman RJ , ShihIM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer – shifting the paradigm. Hum. Pathol.42(7) , 918–931 (2011).
- Vestergaard AL , ThorupK, KnudsenUB et al. Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis. Mol. Hum. Reprod. doi:10.1093/molehr/gar049 (2011) (Epub ahead of print).
- Amemiya S , SekizawaA, OtsukaJ, TachikawaT, SaitoH, OkaiT. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability. Int. J. Gynaecol. Obstet.86(3) , 371–376 (2004).
- Cervelló I , MasA, Gil-SanchisC et al. Reconstruction of endometrium from human endometrial side population cell lines. PLoS ONE 6(6) , e21221 (2011).
- Cheng CW , LicenceD, CookE et al. Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis. J. Pathol. 224(2) , 261–269 (2011).
References
- Guo SW . Epigenetics of endometriosis. Mol. Hum. Reprod.15(10) , 587–607 (2009).
- Nasu K , KawanoY, TsukamotoY et al. Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target. J. Obstet. Gynaecol. Res. 37(7) , 683–695 (2011).
- Vestergaard AL , ThorupK, KnudsenUB et al. Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis. Mol. Hum. Reprod. doi:10.1093/molehr/gar049 (2011) (Epub ahead of print).
- Portela A , EstellerM. Epigenetic modifications and human disease. Nat. Biotechnol.28(10) , 1057–1068 (2010).
- Wu Y , StrawnE, BasirZ, HalversonG, GuoSW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics1(2) , 106–111 (2006).
- Wu Y , StrawnE, BasirZ, HalversonG, GuoSW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil. Steril.87(1) , 24–32 (2007).
- Wiegand KC , ShahSP, Al-AghaOM et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med.363(16) , 1532–1543 (2010).
- Kawano Y , NasuK, LiH et al. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum. Reprod. 26(9) , 2486–2498 (2011).
- Nishida M , NasuK, FukudaJ, KawanoY, NaraharaH, MiyakawaI. Down-regulation of interleukin-1 receptor type 1 expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis. J. Clin. Endocrinol. Metab.89(10) , 5094–5100 (2004).
- Mechtersheimer G , MöllerP. Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors. Am. J. Pathol.134(5) , 961–965 (1989).
- Maradeo ME , CairnsP. Translational application of epigenetic alterations: ovarian cancer as a model. FEBS Lett.585(13) , 2112–2120 (2011).
- Graham JS , KayeSB, BrownR. The promises and pitfalls of epigenetic therapies in solid tumours. Eur. J. Cancer45(7) , 1129–1136 (2009).
References
- Amant F , MoermanP, NevenP, TimmermanD, Van Limbergen E, Vergote I. Endometrial cancer. Lancet366(9484) , 491–505 (2005).
- Prat J , GallardoA, CuatrecasasM, CatasúsL. Endometrial carcinoma: pathology and genetics. Pathology39(1) , 72–87 (2007).
- Zhou XC , DowdySC, PodratzKC, JiangSW. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment. Gynecol. Oncol.107(1) , 143–153 (2007).
- Xiong Y , DowdySC, XueA et al. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Gynecol. Oncol. 96(3) , 601–609 (2005).
- Dewdney SB , RimelBJ, ThakerPH et al. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers. Clin. Cancer Res. 17(8) , 2120–2129 (2011).
- Zannoni GF , VelloneVG, ArenaV et al. Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical study. Virchows Arch. 457(1) , 27–34 (2010).